Search Results - Ubben David
- Showing 1 - 4 results of 4
-
1
Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria? by Gbadoé Adama, Premji Zulfiqarali, Makanga Michael, Tiono Alfred B, Ogutu Bernhards, Ubben David, Marrast Anne, Gaye Oumar
Published in Malaria Journal (2010-01-01)Get full text
Article -
2
Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects by Abdulla Salim, Amuri Baraka, Kabanywanyi Abdunoor M, Ubben David, Reynolds Christine, Pascoe Steve, Fitoussi Serge, Yeh Ching-Ming, Nuortti Marja, Séchaud Romain, Kaiser Günther, Lefèvre Gilbert
Published in Malaria Journal (2010-09-01)Get full text
Article -
3
Similar efficacy and safety of artemether-lumefantrine (Coartem<sup>®</sup>) in African infants and children with uncomplicated falciparum malaria across different body weight rang... by Bassat Quique, González Raquel, Machevo Sónia, Nahum Alain, Lyimo John, Maiga Hamma, Mårtensson Andreas, Bashraheil Mahfudh, Ouma Peter, Ubben David, Walter Verena, Nwaiwu Obiyo, Kipkeu Chemtai, Lefèvre Gilbert, Ogutu Bernhards, Menéndez Clara
Published in Malaria Journal (2011-12-01)Get full text
Article -
4
Malaria in infants aged less than six months - is it an area of unmet medical need? by D’Alessandro Umberto, Ubben David, Hamed Kamal, Ceesay Serign Jawo, Okebe Joseph, Taal Makie, Lama Eugene Kaman, Keita Moussa, Koivogui Lamine, Nahum Alain, Bojang Kalifa, Sonko Aja Adam Jagne, Lalya Honorat Francis, Brabin Bernard
Published in Malaria Journal (2012-12-01)Get full text
Article
